Pyrazolopyrazines acting on cancers via inhibition of cdk12
US-2023192700-A1 · Jun 22, 2023 · US
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 69784083 |
| Family type | — |
| Earliest priority | Mar 6, 2020 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2023192700A1 — Pyrazolopyrazines acting on cancers via inhibition of cdk12 |
Best representative member for this family based on priority and filing country.
US2023192700A1 — Pyrazolopyrazines acting on cancers via inhibition of cdk12 (published Jun 22, 2023)
Related publications in this family.
US-2023192700-A1 · Jun 22, 2023 · US